Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neuroimmunomodulation ; 24(4-5): 276-281, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29510394

RESUMO

Prompted by findings suggesting immune instability in infantile bilateral striatal necrosis (IBSN), we evaluated levels of proinflammatory (tumor necrosis factor α, interleukin [IL]-1ß, IL-6, interferon [IFN]γ) and anti-inflammatory (IL-10 and IL-1ra) cytokines produced by peripheral blood mononuclear cells (PBMC) from 6 children with IBSN and 11 age-matched controls. Compared to controls, non-stimulated PBMC from the IBSN group produced a significantly lower level of IL-1ra (by 38%; p < 0.001) and significantly lower levels of TNFα, IL-1ß, and IFNγ (by 36% [p < 0.001], 25% [p = 0.06], and 32% [p < 0.02]) under PBMC stimulation. The severe cachexia manifesting shortly after IBSN onset may impair the immunological state, placing patients at risk of death from hyperpyrexia and sepsis.


Assuntos
Citocinas/sangue , Citocinas/imunologia , Leucócitos Mononucleares/imunologia , Leucócitos Mononucleares/metabolismo , Degeneração Estriatonigral/congênito , Adolescente , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Degeneração Estriatonigral/sangue , Degeneração Estriatonigral/diagnóstico , Degeneração Estriatonigral/imunologia
2.
J Neurol ; 249(9): 1206-10, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12242540

RESUMO

Multiple System Atrophy (MSA) and idiopathic Parkinson's disease (PD) can be difficult to distinguish. There is an ongoing debate about the diagnostic value of the growth-hormone response to clonidine (CGH-test) in PD and MSA. We investigated whether the CGH-test can identify individual patients in the early stages of PD (n = 21) and Striatonigral Degeneration (SND, n = 11), a particular variety of MSA. Patients were diagnosed on the basis of clinical criteria and IBZM-SPECT. Clonidine induced a greater total serum growth-hormone production in PD than in SND (p = 0.01). However, taking the difference in prevalence of PD and SND into account, and because of the low likelihood ratios of the test, an increase of GH after clonidine increases the pre-test probability for PD by about only 5 %, while an absent response of GH also increases the pre-test probability for SND by about 5 %. We conclude that the CGH-test discriminates between groups of patients with PD and SND, but has little practical diagnostic value for identifying individual patients.


Assuntos
Clonidina , Hormônio do Crescimento/metabolismo , Doença de Parkinson/diagnóstico , Degeneração Estriatonigral/diagnóstico , Idoso , Análise de Variância , Distribuição de Qui-Quadrado , Diagnóstico Diferencial , Hormônio do Crescimento/sangue , Humanos , Pessoa de Meia-Idade , Doença de Parkinson/sangue , Estatísticas não Paramétricas , Degeneração Estriatonigral/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...